Baricitinib Impurity 13 | CAS 7400-05-7 - Request Quote
Baricitinib Impurity 13
| SZ CAT No: | SZ-B038024 |
| CAS No | 7400-05-7 |
| Mol.F. | C10H17N3O3S |
| Mol.Wt. | 259.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Baricitinib Impurity 13 is chemically 6-Amino-5-(2,2-diethoxyethyl)-2-thioxo-2,3-dihydropyrimidin-4(1H)-one. Baricitinib Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Baricitinib Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Baricitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 7400-05-7
Purchase 7400-05-7
Order 7400-05-7
Enquire 7400-05-7
price of 7400-05-7
7400-05-7 Supplier
7400-05-7 Manufacturer
7400-05-7 Exporter
buy high quality Baricitinib Impurity 13
Purchase Baricitinib Impurity 13
Baricitinib Impurity 13 suppliers
Baricitinib Impurity 13 manufacturers
Baricitinib Impurity 13 price
Order Baricitinib Impurity 13
Enquire Baricitinib Impurity 13
Baricitinib Impurity 13 cost
Baricitinib Impurity 13 Supplier
Baricitinib Impurity 13 Distributor
Baricitinib Impurity 13 for Method Validation
Baricitinib Reference Standard
Baricitinib Impurity 13 for ANDA Filing
Baricitinib Impurity 13 for Forced Degradation Studies
Baricitinib Impurity 13 Identification Standards
Baricitinib Impurity 13 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


